Diminished expression of CD59 on activated CD8+ T cells undergoing apoptosis in systemic lupus erythematosus and Sjogren's syndrome

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 293-299

  Tsunoda, S ^a   Kawano, M ^a   Koni, I ^a   Kasahara, Y ^a   Yachie, A ^a   Miyawaki, T ^b   Seki, H ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CD8 ANTIGEN; PREDNISOLONE; STEROID;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD59; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMMUNITY, NATURAL; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; PREDNISOLONE; PULSE THERAPY, DRUG; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 0034061463     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00674.x     Document Type: Article

References (33)

1. Rose LM, Latchman DS, Isenberg DA. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: A review. Br J Rheumatol 1997;36:158-63.
2. Sneller MC, Wang J, Dale JK et al. Clinical, immunologic, and genetic features with abnormal lymphocyte apoptosis. Blood 1997;1:175-210.
3. Mountz JD, Wo J, Cheng J, Zhou T. Autoimmune disease; A problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
4. Fox RI. Clinical features, pathogenesis, and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1996;8:436-45.
5. Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: Life and death in the Fas lane. Immunol Today 1992;13:427-8.
6. VanHouten N, Budd RC. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J Immunol 1992;149:2513-7.
7. Emlen W, Niebur J, Kadera R. Accelerated in vivo apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
8. Chan EY, Ko SC, Lau CS. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus. Asian Pac J Allergy Immunol 1997;15:3-7.
9. Lorentz HM, Grunke M, Hieronymus T et al. In vivo apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997;40:306-17.
10. Ogawa N, Dang H, Kong L, Anaya JM, Liu GT, Talal N. Lymphocyte apoptosis and apoptosis-associated gene expression in Sjögren's syndrome. Arthritis Rheum 1996;39:1875-85.
11. Rose LM, Latchman DS, Isenberg DA. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Br J Rheumatol 1995;34:316-20.
12. Aringer M, Wintersberger W, Steiner CW et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1423-30.
13. Ichikawa Y, Arimori K, Yoshida M et al. Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome. Clin Exp Rheumatol 1995;13:307-13.
14. Kawano M, Tsunoda S, Koni I, Muramoto H, Yachie A, Seki H. Decreased expression of 20-kD homologous restriction factor (HRF20, CD59) on T lymphocytes in Epstein - Barr virus-induced infectious mononucleosis. Clin Exp Immunol 1997;108:260-5.
15. + T lymphocytes in Epstein - Barr virus induced infectious mononucleosis. Blood 1992;80:452-8.
16. + T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 1993;82:521-7.
17. Walsh LA, Tone M, Thiru S, Waldmann H. The CD59 antigen - A multifunctional molecule. Tissue Antigens 1992;40:213-20.
18. Groux H, Huet S, Aubrit F, Tran HC, Broumsell L, Bernard A. A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation. J Immunol 1989;142:3013-20.
19. Korty PE, Brando C, Shevch EM. CD59 functions as a signal-transducing molecule for human T cell activation. J Immunol 1991;146:4092-8.
20. Hahn WC, Mene E, Bothwell ALM, Sims PJ, Biere BE. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 1992;256:1805-7.
21. Seki H, Iwai K, Kanegane H et al. Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell Immunol 1995;163:30-6.
22. Dive C, Gregory DG, Phipps DJ, Evans DL, Milner AE, Wullie AH. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1992;113:275-85.
23. + cells in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 1998; 30:1407-11.
24. Ichikawa Y, Shimizu H, Yoshida M, Arimori S. Activation of T cell subsets in the peripheral blood of patients with Sjögren's syndrome. Multicolor flow cytometric analysis. Arthritis Rheum 1990;33:1674-81.
25. Kumagai S, Yanagida H, Nakao K. Decreased expression of bcl-2 protein and its possible role on the apoptotic death of peripheral T cells in patients with systemic lupus erythematosus (SLE). Arthritis Rheum 1994;37:S162.
26. Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993;178:427-38.
27. Mollereau B, Blaminique D, Deas O et al. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes. T cells manifesting proliferative unreponsiveness are preferentially susceptible to CD95-mediated apoptosis. J Immunol 1997;159:2668-77.
28. + T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol 1996;106:218-29.
29. Decken M, Ticchioni M, Mari B, Mary D, Bernard A. The glycosylphosphatidylinositol-anchored CD59 protein stimulated both T cell receptor Z/ZAP-70-dependent and -independent signaling pathways in T cells. Eur J Immunol 1995;25:1815-22.
30. Deckert M, Ticchioni M, Bernard A. Endocytosis of GPI-anchored proteins in human lymphocytes: Role of glycolipid-based domains, actin cytoskeleton, and protein kinases. J Cell Biol 1996;133:791-9.
31. Tomita A, Okada N, Okada H. Comparative studies of decay-accelerating factor and HLA-DR within the CD8-brightly positive population. Eur J Immunol 1991;21:1843-8.
32. Tsuji S, Kaji K, Nagasawa S. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J Biochem 1994;116:794-800.
33. Jones J, Morgan BP. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leukocytes: Functional relevance and role in inflammation. Immunology 1995;86:651-60.